Ziihera
Payments companies reported to CMS as associated with Ziihera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ziihera, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ziihera
These are the largest totals companies reported as associated with Ziihera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Morse | Durham, NC | Hematology & Oncology | $129,661.25 |
| Raji Shameem | Orlando, FL | Medical Oncology | $105,024.34 |
| Benjamin Weinberg | Washington, DC | Hematology & Oncology | $52,806.81 |
| Mark Davis | Fort Worth, TX | Medical | $39,644.37 |
| Fadi Braiteh | Las Vegas, NV | Medical Oncology | $33,504.37 |
| Sameh Mikhail | Columbus, OH | Hematology & Oncology | $33,458.10 |
| Walid Shaib | New Haven, CT | Hematology & Oncology | $33,349.37 |
| Marjorie Hein | Duarte, CA | Family | $31,096.46 |
| Paul Oberstein | New York, NY | Medical Oncology | $28,829.77 |
| Abdalla Sholi | Williamsport, PA | Hematology & Oncology | $25,130.03 |
Prescribed Ziihera?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.